Product Name | MF | CAS | Details |
---|
PI5P4Kα-IN-1 | C20H17N3O2S | 2428737-31-7 | Details |
HP210 | 728039-52-9 | Details |
JG-23 | 2640819-75-4 | Details |
MAO-IN-3 | 797805-26-6 | Details |
α-Glucosidase-IN-29 | 2949513-11-3 | Details |
Necrocide 1 | C23H27NO3 | 1247028-61-0 | Details |
NSC 288387 | C19H16N4O3 | 61369-43-5 | Details |
MKA031 | 2951012-00-1 | Details |
NH2-c[X-R-L-S-X]-K-G-P-(D-2Nal) | 2891469-81-9 | Details |
DNA Gyrase-IN-8 | 2925308-76-3 | Details |
VU0364739 | C26H27FN4O2 | 1244639-78-8 | Details |
(S,R)-CFT8634 | C37H45F3N6O5 | 2704617-95-6 | Details |
INX-SM-6 | C32H36N2O6S | 2734878-16-9 | Details |
WH-10417-099 | C52H62N8O13S | 2769753-42-4 | Details |
SIMR3030 | C27H29N3O2 | 2708270-99-7 | Details |
XMT-1519 conjugate-1 | C101H149N23O42 | 2720500-19-4 | Details |
CCT374705 | 2640647-90-9 | Details |
P2X3-IN-1 | 2823331-49-1 | Details |
CHI-000-667 | C21H16ClNO4S | 905794-70-9 | Details |
Fosnetupitant chloride monohydrochloride | C31H36F6N4O5P. HCl. Cl | 1643757-72-5 | Details |
Clezutoclax | C83 H102 N12 O24 S2 | 1949843-71-3 | Details |
MC-Gly-Gly-Phe-Gly-amide-cyclopropanol-amide-Exatecan | C54H58FN9O13 | 2414254-41-2 | Details |
KRAS G12D mutation regulator 4 | C33H33FN6O2 | 2621927-57-7 | Details |
MethylCBI-azaindole-benzamide-MOM-Boc-ethylenediamine-D | C44H51ClN6O10 | 2222445-87-4 | Details |
vc-PABC-DM1 | C53H75ClN8O13S | 1416792-90-9 | Details |
Antifungal agent 50 | C25H20ClN5O2S | 2896209-33-7 | Details |
QR-0217 | C19H13NO3 | 1027786-12-4 | Details |
Nurr1 agonist 4 | C12H10O4 | 87645-58-7 | Details |
Nrf2-IN-3 | C22H26N4O4S | 6325-13-9 | Details |
Antitumor agent-97 | C24H34O3 | 2654024-16-3 | Details |
Ac-Val-Gln-aIle-Val-aTyr-Lys-NH2 | 2858785-68-7 | Details |
GGFG-amide-glycol-amide-Exatecan | 2866301-18-8 | Details |
H3B-968 | 2912294-90-5 | Details |
IDO1/TDO-IN-6 | 2948772-71-0 | Details |
β-catenin-IN-6 | C22H19ClN6O | 1039731-99-1 | Details |
I-287 | C30H30ClFN4O4 | 2014368-93-3 | Details |
Mps1-IN-6 (Compound 9) | C24H27N7O2 | 2489220-49-5 | Details |
TAM558 | 1802499-21-3 | Details |
(1R,4S)-Yimitasvir diphosphate | 2734870-15-4 | Details |
Ferric nitrilotriacetate | C6H6FeNO6 | 16448-54-7 | Details |
Antifungal agent 48 | 2142003-75-4 | Details |
FHND5071 | 2761152-16-1 | Details |
HDAC-IN-59 | 2944459-43-0 | Details |
JT002 | 2238820-43-2 | Details |
NH2-methylpropanamide-Exatecan TFA | 1817857-35-4 | Details |
p-fin4 | 2883747-74-6 | Details |
UZH1b | 2814392-17-9 | Details |
Val-Ala-PABC-Exatecan | 2845164-91-0 | Details |
Urease-IN-6 | C18H19N3OS | 362502-79-2 | Details |
Mal-EGGGG-PEG8-amide-bis(deoxyglucitol) | C55H94N10O31 | 2360920-01-8 | Details |
NK3R-IN-1 | 2854331-14-7 | Details |
rel-(2S,3R)-Voruciclib hydrochloride | 1253647-46-9 | Details |
α-Glucosidase-IN-28 | 2949513-10-2 | Details |
AM841 | C26H39NO3S | 871978-21-1 | Details |
Neurotensin(8-13) 3TFA(60482-95-3(free base)) | 2952825-79-3 | Details |
GPR52 receptor modulator 1 | C19H14F4N4O | 2642079-89-6 | Details |
Val-Ala-PAB-MMAE | C55H88N8O11 | 1912408-92-4 | Details |
Osivelotor | C20H22N2O6 | 2417955-18-9 | Details |
IDO1-IN-22 | 2126853-16-3 | Details |
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan | 1599439-54-9 | Details |
NH2-c[X-R-L-S-X]-K-G-P-(D-1Nal) | 2891469-80-8 | Details |
CYT296 | C18H16O2S | 1799392-31-6 | Details |
Mal-PEG8-Val-Ala-PAB-Exatecan | C66H85FN8O20 | 2679821-39-5 | Details |
NaPi2b-IN-2 | C41H47ClF3N5O5S | 2227445-31-8 | Details |
Glucocorticoid receptor agonist-2 Ala-Ala-Mal | C47H50F2N4O12 | 2166376-64-1 | Details |
MEL24 | C17H18N4O3 | 642072-48-8 | Details |
Anticancer agent 105 | 2450987-57-0 | Details |
Antifungal agent 49 | 1414861-21-4 | Details |
HDAC-IN-60 | 2944459-58-7 | Details |
Propargyl-PEG4-GGFG-DXd | 2762518-94-3 | Details |
Farletuzumab ecteribulin | 2407465-18-1 | Details |
Azilsartan mepixetil potassium | C36H34N6O8.K | 2153458-32-1 | Details |
Xeniafaraunol A | C20H28O2 | 161162-29-4 | Details |
Maytansinoid B | C36H51ClN4O10 | 1628543-40-7 | Details |
ZINC00784494 | C20H14N2O3S | 317328-17-9 | Details |
PRMT5-IN-29 | 2242788-69-6 | Details |
SN38-COOH | C26H24N2O8 | 2170118-23-5 | Details |
SHP2-IN-22 | 2802453-88-7 | Details |
D1R antagonist 1 | 2983777-67-7 | Details |
PBR28 | C21H20N2O3 | 253307-65-2 | Details |
Glucocerebrosidase-IN-1 hydrochloride | 2279945-77-4 | Details |
(RS)-K20 | 2915618-92-5 | Details |
FLT3-IN-19 | 2237234-48-7 | Details |
SC239 | C65H84N10O11 | 1977557-97-3 | Details |
MiTMAB | C17H38BrN | 2253617-91-1 | Details |
COX-2-IN-30 | 1160498-08-7 | Details |
STAT3 degrader-2 | C59H62N9O13P | 2497583-03-4 | Details |
PPARδ agonist 9 | C26H28ClF3N4O3S | 928023-21-6 | Details |
DprE1-IN-9 | 2906099-98-5 | Details |
ZL-2201 | 2865115-39-3 | Details |
Cyclotheonellazole A | 2094993-48-1 | Details |
(Aminooxy)acetamide-Val-Cit-PAB-MMAE | 2446645-88-9 | Details |
MAT2A-IN-10 | C27H24F2N6O4 | 2924825-23-8 | Details |
AChE-IN-31 | 1325209-07-1 | Details |
Targeting the bacterial sliding clamp peptide 46 | 2756997-82-5 | Details |
(R)-Necrocide 1 | 1247028-62-1 | Details |
PD-L1-IN-2 | 2894733-91-4 | Details |
KRAS G12C mutant protein inhibitor A-1 | C31H26ClF4N7O2 | 2658538-04-4 | Details |
JAK-IN-26 | C22H24N6O3 | 2417134-93-9 | Details |
Mc-Alanyl-Alanyl-Asparagine-PAB-MMAE | C67H101N11O16 | 1638970-46-3 | Details |
Product Total: Product Page: | ||||
145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 |